Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MYOV Myovant Sciences > Detailed Quotes

MYOV Myovant Sciences

Watchlist
26.9000.0000.00%
Trading Session  01/27 12:58 ET
High
26.900
Open
26.880
Turnover
8.21M
Low
26.880
Pre Close
26.900
Volume
305.08K
Market Cap
2.60B
P/E(TTM)
Loss
52wk High
27.025
Shares
96.80M
P/E(Static)
Loss
52wk Low
7.670
Float Cap
1.24B
Bid/Ask %
-44.62%
Historical High
30.900
Shs Float
46.18M
Volume Ratio
1.12
Historical Low
4.140
Dividend TTM
--
Div Yield TTM
--
P/B
-5.07
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.66%
Amplitude
0.07%
Avg Price
26.895
Lot Size
1
Float Cap
1.24B
Bid/Ask %
-44.62%
Historical High
30.900
Shs Float
46.18M
Volume Ratio
1.12
Historical Low
4.140
Dividend TTM
--
P/B
-5.07
Dividend LFY
--
Turnover Ratio
0.66%
Amplitude
0.07%
Avg Price
26.895
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.
CEO: Mr. David C. Marek
Market: NYSE
Listing Date: 10/27/2016
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist